CEUS LI-RADS in Combination With the Serum Biomarker-Based ASAP Model Improves the Diagnostic Performance of HCC in High-Risk Patients
Article in Ultrasound in Medicine & Biology (August 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States.
Article in Hepatology (June 2024)
Diagnostic performance comparisons of two commonly used multi-biomarker-based scores for detection of hepatocellular carcinoma in non-alcoholic fatty liver disease
Article in iLiver (June 2024)